Screener
Ionis Pharmaceuticals IONS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| June 30, 2026 | Amortized / Cost | Gross Unrealized / Gains | Gross Unrealized / Losses | Estimated / Fair Value |
|---|---|---|---|---|
| Debt securities issued by U.S. government agencies | 26,439 | 26 | (20) | 26,445 |
| Debt securities issued by the U.S. Treasury (1) | 467,565 | 88 | (604) | 467,049 |
| Debt securities issued by states of the U.S. and political subdivisions of the states | 5,025 | - | (3) | 5,022 |
| Total debt securities with a maturity of one year or less | 1,137,717 | 425 | (1,101) | 1,137,041 |
| Corporate debt securities | 349,545 | 87 | (1,692) | 347,940 |
| Debt securities issued by U.S. government agencies | 119,701 | 4 | (878) | 118,827 |
| Debt securities issued by the U.S. Treasury | 181,168 | - | (1,340) | 179,828 |
| Debt securities issued by states of the U.S. and political subdivisions of the states | 731 | - | (1) | 730 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's short-term investments?
- Ionis Pharmaceuticals (IONS) reported short-term investments of $1.14B in Q2 2026.
- How has Ionis Pharmaceuticals's short-term investments changed year-over-year?
- Ionis Pharmaceuticals's short-term investments decreased by 14.5% year-over-year, from $1.33B to $1.14B.
- What is the long-term trend for Ionis Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's short-term investments has grown at a 1.1% compound annual growth rate (CAGR), from $1.49B to $1.58B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Ionis Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude